Carna Biosciences, Inc. (TYO:4572)

Carna Biosciences Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,060	2,108	2,889	3,379	3,817	4,299
Cash & Short-Term Investments	1,060	2,108	2,889	3,379	3,817	4,299
Cash Growth	-64.97%	-27.03%	-14.50%	-11.47%	-11.21%	-12.53%
Receivables	71	87	788	182	1,243	129
Inventory	163	154	140	118	110	104
Other Current Assets	295	388	374	425	148	176
Total Current Assets	1,589	2,737	4,191	4,104	5,318	4,708
Property, Plant & Equipment	-	-	105	100	51	53
Long-Term Investments	46	34	51	59	59	70
Other Intangible Assets	-	-	1	1	2	3
Other Long-Term Assets	-	1	1	2	2	1
Total Assets	1,635	2,772	4,349	4,266	5,432	4,835
Accounts Payable	-	2	1	1	2	1
Current Portion of Long-Term Debt	18	19	120	151	239	189
Current Portion of Leases	-	8	6	-	-	-
Current Income Taxes Payable	136	180	218	265	332	344
Current Unearned Revenue	-	-	-	-	177	169
Other Current Liabilities	30	13	30	19	24	24
Total Current Liabilities	184	222	375	436	774	727
Long-Term Debt	-	8	28	148	300	239
Long-Term Leases	-	24	28	-	-	-
Other Long-Term Liabilities	61	44	42	42	45	45
Total Liabilities	245	298	473	626	1,119	1,011
Common Stock	10	2,447	2,076	1,382	1,056	558
Additional Paid-In Capital	2,192	6,198	5,827	5,133	4,808	4,310
Retained Earnings	-865	-6,253	-4,075	-2,922	-1,572	-1,038
Comprehensive Income & Other	53	82	48	47	21	-6
Shareholders' Equity	1,390	2,474	3,876	3,640	4,313	3,824
Total Liabilities & Equity	1,635	2,772	4,349	4,266	5,432	4,835
Total Debt	18	59	182	299	539	428
Net Cash (Debt)	1,042	2,049	2,707	3,080	3,278	3,871
Net Cash Growth	-64.53%	-24.31%	-12.11%	-6.04%	-15.32%	-7.57%
Net Cash Per Share	55.40	114.41	161.13	226.18	258.20	314.74
Filing Date Shares Outstanding	19.1	19.1	17.14	16.34	13.48	12.4
Total Common Shares Outstanding	19.1	19.1	17.14	14.21	13.31	12.4
Working Capital	1,405	2,515	3,816	3,668	4,544	3,981
Book Value Per Share	72.76	129.55	226.07	256.14	324.08	308.34
Tangible Book Value	1,390	2,474	3,875	3,639	4,311	3,821
Tangible Book Value Per Share	72.76	129.55	226.02	256.07	323.93	308.10
Order Backlog	-	13.09	39.76	58.12	257.29	214.93

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.